Updates are available Correction dated 2021-09-16
Click to view Correction: https://doi.org/10.1038/s41591-021-01504-5
-
Authors
Boughton, Charlotte K. https://orcid.org/0000-0003-3272-9544
Tripyla, Afroditi
Hartnell, Sara
Daly, Aideen
Herzig, David
Wilinska, Malgorzata E.
Czerlau, Cecilia https://orcid.org/0000-0002-9453-2766
Fry, Andrew
Bally, Lia https://orcid.org/0000-0003-1993-7672
Hovorka, Roman https://orcid.org/0000-0003-2901-461X
-
Funding
Funding for this research was provided by:
CB was supported by a grant from The Novo Nordisk UK Research Foundation
LB was supported by a grant of the Swiss Society for Endocrinology and a grant of the Diabetes and Swiss Kidney Foundation.
Supported by National Institute for Health Research Cambridge Biomedical Research Centre.
- License Information
-
More Information
Article History
Received: 1 March 2021
Accepted: 28 June 2021
First Online: 4 August 2021
Change Date: 16 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-021-01504-5
Competing interests
: S.H. serves as a member of the Sigma (Dexcom) and Medtronic advisory boards, is a director of Ask Diabetes Ltd, providing training and research support in healthcare settings, and reports having received training honoraria from Medtronic and Sanofi. M.E.W. reports receiving license fees from B. Braun, patents related to closed-loop and being a consultant at CamDiab. R.H. reports having received speaker honoraria from Eli Lilly, Dexcom and Novo Nordisk, receiving license fees from B. Braun and Medtronic, patents related to closed-loop and being director at CamDiab. C.K.B., L.B., A.T., A.D., D.H., C.C. and A.F. declare no competing interests associated with this manuscript.
